Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
January 22, 2003
U.S. IMMUNIZATION NEWS
"Avant Wins Contract for Oral Vaccine for Anthrax and Plague" New York Times (www.nytimes.com) (01/22/03) P. C12; Pollack, Andrew
Avant Immunotherapeutics received a contract from the Defense Department's DynPort Vaccine, the primary contractor for development of vaccines against possible biowarfare agents, that involves the creation of a combination vaccine against anthrax and plague. The vaccine would only require one oral dose, rather than multiple injections over a period of time. The contract, worth $2.8 million initially and up to $8 million over the next two years, will be completed by Avant in up to 10 years.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.